3M (MMM)

• Market cap: $73.2B
• 1 day: 0.38%
• 5 days: 2.41%
• 1 month: -5.41%
• 3 months: -10.03%
• 6 months: 8.90%
• Year to date: 7.10%
• 1 year: 43.93%
• 5 years: 9.36%
• 10 years: 6.23%
• Sector: Industrials
• Industry: Conglomerates

About: 3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.

Employees: 61,500

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

57% more first-time investments, than exits

New positions opened: 225 | Existing positions closed: 143

56% more call options, than puts

Call options by funds: $1.54B | Put options by funds: $988M

35% more funds holding in top 10

Funds holding in top 10: 26 [Q3] → 35 (+9) [Q4]

2.07% more ownership

Funds ownership: 65.33% [Q3] → 67.39% (+2.07%) [Q4]

2% more funds holding

Funds holding: 2,059 [Q3] → 2,092 (+33) [Q4]

4% more capital invested

Capital invested by funds: $48.8B [Q3] → $50.8B (+$1.99B) [Q4]

19% less repeat investments, than reductions

Existing positions increased: 670 | Existing positions reduced: 826

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $100 28% downside
• Avg. target: $145 4% upside
• High target: $179 29% upside

5 analyst ratings

• positive: 3 60%
• neutral: 1 20%
• negative: 1 20%

RBC Capital Deane Dray 31% 1-year accuracy 17 / 54 met price target	28% downside $100	Underperform Maintained	23 Apr 2025
Barclays Julian Mitchell 36% 1-year accuracy 46 / 128 met price target	18% upside $164	Overweight Maintained	23 Apr 2025
Citigroup Andrew Kaplowitz 36% 1-year accuracy 31 / 86 met price target	2% upside $142	Neutral Maintained	14 Apr 2025
JP Morgan Stephen Tusa 47% 1-year accuracy 16 / 34 met price target	1% upside $140	Overweight Maintained	8 Apr 2025
B of A Securities Andrew Obin 38% 1-year accuracy 8 / 21 met price target	29% upside $179	Buy Maintained	6 Mar 2025